Cytosine methylation and hydroxymethylation mark DNA for elimination in Oxytricha trifallax.
BACKGROUND
Cytosine methylation of DNA is conserved across eukaryotes and plays important functional roles regulating gene expression during differentiation and development in animals, plants and fungi. Hydroxymethylation was recently identified as another epigenetic modification marking genes important for pluripotency in embryonic stem cells.


RESULTS
Here we describe de novo cytosine methylation and hydroxymethylation in the ciliate Oxytricha trifallax. These DNA modifications occur only during nuclear development and programmed genome rearrangement. We detect methylcytosine and hydroxymethylcytosine directly by high-resolution nano-flow UPLC mass spectrometry, and indirectly by immunofluorescence, methyl-DNA immunoprecipitation and bisulfite sequencing. We describe these modifications in three classes of eliminated DNA: germline-limited transposons and satellite repeats, aberrant DNA rearrangements, and DNA from the parental genome undergoing degradation. Methylation and hydroxymethylation generally occur on the same sequence elements, modifying cytosines in all sequence contexts. We show that the DNA methyltransferase-inhibiting drugs azacitidine and decitabine induce demethylation of both somatic and germline sequence elements during genome rearrangements, with consequent elevated levels of germline-limited repetitive elements in exconjugant cells.


CONCLUSIONS
These data strongly support a functional link between cytosine DNA methylation/hydroxymethylation and DNA elimination. We identify a motif strongly enriched in methylated/hydroxymethylated regions, and we propose that this motif recruits DNA modification machinery to specific chromosomes in the parental macronucleus. No recognizable methyltransferase enzyme has yet been described in O. trifallax, raising the possibility that it might employ a novel cytosine methylation machinery to mark DNA sequences for elimination during genome rearrangements.
John R
JR
Bracht
David H
DH
Perlman
Laura F
LF
Landweber
D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D003596:Cytosine / Q000032:analysis* / Q000378:metabolism; D019175:DNA Methylation / Q000187:drug effects; D016054:DNA, Protozoan / Q000378:metabolism*; D000077209:Decitabine; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015321:Gene Rearrangement; D059014:High-Throughput Nucleotide Sequencing; D013058:Mass Spectrometry; D008969:Molecular Sequence Data; D016813:Oxytricha / Q000187:drug effects / Q000235:genetics*; D017422:Sequence Analysis, DNA
D016054:DNA, Protozoan; D004791:Enzyme Inhibitors; D000077209:Decitabine; D003596:Cytosine; D001374:Azacitidine